High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-emitting multiple sclerosis (RRMS) receiving subcutaneous interferon β-1a (scIFNβ-1a)

被引：0
|
作者：
Hupperts, Raymond [1 ]
Smolders, Joost [2 ,3 ]
Vieth, Reinhard [3 ]
Holmoy, Trygve [4 ,5 ]
Marhardt, Kurt [6 ]
Schluep, Myriam [7 ]
Killestein, Joep [8 ]
Barkhof, Frederik [9 ,10 ,11 ]
Grimaldi, Luigi Maria [12 ,13 ]
Beelke, Manolo [14 ]
机构：
[1] Maastricht Univ, Med Ctr, Orbis Med Ctr, Sittard, Netherlands
[2] Canisus Wilhelmina Ziekenhuis, Nijmegen, Netherlands
[3] Univ Toronto, Nijmegen, Netherlands
[4] Akershus Univ Hosp, Oslo, Norway
[5] Univ Oslo, Oslo, Norway
[6] Merck GmbH, Vienna, Austria
[7] CHU Vaudois, Serv Neurol, Lausanne, Switzerland
[8] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands
[9] Vrije Univ Amsterdam, Med Ctr, Radiol & Nucl Med, Amsterdam, Netherlands
[10] Univ Coll London, Inst Neurol, Amsterdam, Netherlands
[11] Univ Coll London, Inst Healthcare Engn, Amsterdam, Netherlands
[12] Fdn Ist G Giglio CefalU, UOC Neurol, Cefalu, Italy
[13] Fdn Ist G Giglio CefalU, Multiple Sclerosis Ctr, Cefalu, Italy
[14] Worldwide Clin Trials GmbH, Germering, Germany
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S44.005
引用
收藏
页数：3
相关论文
共 29 条
  • [1] High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a.
    Smolders, J.
    Hupperts, R.
    Vieth, R.
    Holmoy, T.
    Marhardt, K.
    Schluep, M.
    Killestein, J.
    Barkhof, F.
    Grimaldi, L. M. E.
    Beelke, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 50 - 50
  • [2] Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a
    Hupperts, Raymond
    Smolders, Joost
    Vieth, Reinhold
    Holmoy, Trygve
    Marhardt, Kurt
    Schluep, Myriam
    Killestein, Joep
    Barkhof, Frederik
    Beelke, Manolo
    Grimaldi, Luigi M. E.
    NEUROLOGY, 2019, 93 (20) : E1906 - E1916
  • [3] Methylprednisolone as add-on to Interferon-β-1a in treatment naive relapsing-remitting multiple sclerosis (RRMS) patients reduces the annualized relapse rate
    Sorensen, P. S.
    Ravnborg, M.
    Andersson, M. L.
    Elovaara, I.
    Jongen, P.
    Constantinescu, C.
    Beer, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S202 - S202
  • [4] Driving simulator performance in relapsing remitting multiple sclerosis (RRMS) during 12 months of therapy with Interferon β 1A
    Kotterba, S. V.
    Lange, S.
    Yavuz, E.
    Yalcin, S.
    Orth, M.
    Sindern, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 124 - 125
  • [5] Efficacy and safety of oral contraceptives as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a multicenter, randomized investigator-run clinical trial
    Pozzilli, C.
    De Giglio, L.
    Barletta, V.
    Marinelli, F.
    De Angelis, F.
    Gallo, V.
    Pagano, V. A.
    Bassano, M. A.
    Piattella, M. C.
    Tomassini, V.
    Pantano, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 515 - 516
  • [6] Daytime sleepiness and fatigue in relapsing remitting multiple sclerosis (RRMS) during 12-month therapy with interferon β 1a
    Kotterba, S
    Lange, S
    Yavuz, E
    Yalcin, S
    Sindern, E
    SLEEP, 2004, 27 : 318 - 318
  • [7] Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
    Smolders, Joost
    Hupperts, Raymond
    Barkhof, Frederik
    Grimaldi, Luigi M. E.
    Holmoy, Trygve
    Killestein, Joep
    Rieckmann, Peter
    Schluep, Myriam
    Vieth, Reinhold
    Hostalek, Ulrike
    Ghazi-Visser, Lizette
    Beelke, Manolo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 (1-2) : 44 - 49
  • [8] High-dose subcutaneous interferon β-1a is efficacious in transitional multiple sclerosis, a group at high risk for progression in disability
    Paty, DW
    Blumhardt, LD
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 503 - 503
  • [9] The combination of subcutaneous interferon β 1a with oral contraceptives with high dose oestrogens improves cognitive impairment of women with multiple sclerosis
    De Giglio, L.
    De Angelis, F.
    Marinelli, F.
    Leonardi, L.
    Barletta, V.
    Pantano, P.
    Tomassini, V.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 508 - 509
  • [10] Clinical course of multiple sclerosis after a therapy optimization to high-dose subcutaneous interferon β-1A: An observational study orca in the Czech Republic and Slovakia
    Tvaroh, A.
    Mares, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1067 - 1067
123